+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Glioblastoma Market and Competitive Landscape - 2020

  • ID: 5023489
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Glioblastoma Market and Competitive Landscape - 2020, provides comprehensive insights into the Glioblastoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Glioblastoma market size and drug sales. It also provides insights into Glioblastoma epidemiology and late stage pipeline.

This research covers the following: Glioblastoma treatment options, Glioblastoma late stage clinical trials pipeline, Glioblastoma prevalence by countries, Glioblastoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Glioblastoma pipeline: Find out drugs in clinical trials for the treatment of Glioblastoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Glioblastoma epidemiology: Find out the number of patients diagnosed (prevalence) with Glioblastoma by countries
  • Glioblastoma drugs: Identify key drugs marketed and prescribed for Glioblastoma in the US, including trade name, molecule name, and company
  • Glioblastoma drugs sales: Find out the sales value for Glioblastoma drugs by countries
  • Glioblastoma market valuations: Find out the market size for Glioblastoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Glioblastoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Glioblastoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Glioblastoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze Glioblastoma drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Glioblastoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Glioblastoma Treatment Options

2. Glioblastoma Pipeline Insights
2.1. Glioblastoma Phase 3 Clinical Trials
2.2. Glioblastoma Phase 2 Clinical Trials
2.3. Glioblastoma Phase 1 Clinical Trials

3. Glioblastoma Epidemiology Analysis by Countries

4. US Glioblastoma Market Insights
4.1. Marketed Drugs for Glioblastoma in US
4.2. US Glioblastoma Market Size & Forecast
4.3. US Glioblastoma Drugs Sales & Forecast
4.4. US Glioblastoma Market Share Analysis

5. Germany Glioblastoma Market Insights
5.1. Marketed Drugs for Glioblastoma in Germany
5.2. Germany Glioblastoma Market Size & Forecast
5.3. Germany Glioblastoma Drugs Sales Forecast
5.4. Germany Glioblastoma Market Share Analysis

6. France Glioblastoma Market Insights
6.1. Marketed Drugs for Glioblastoma in France
6.2. France Glioblastoma Market Size & Forecast
6.3. France Glioblastoma Product Sales Forecast
6.4. France Glioblastoma Market Share Analysis

7. Italy Glioblastoma Market Insights
7.1. Marketed Drugs for Glioblastoma in Italy
7.2. Italy Glioblastoma Market Size & Forecast
7.3. Italy Glioblastoma Product Sales Forecast
7.4. Italy Glioblastoma Market Share Analysis

8. Spain Glioblastoma Market Insights
8.1. Marketed Drugs for Glioblastoma in Spain
8.2. Spain Glioblastoma Market Size & Forecast
8.3. Spain Glioblastoma Product Sales Forecast
8.4. Spain Glioblastoma Market Share Analysis

9. UK Glioblastoma Market Insights
9.1. Marketed Drugs for Glioblastoma in UK
9.2. UK Glioblastoma Market Size & Forecast
9.3. UK Glioblastoma Product Sales Forecast
9.4. UK Glioblastoma Market Share Analysis

10. Europe Glioblastoma Market Insights
10.1. Europe Glioblastoma Market Size & Forecast
10.2. Europe Glioblastoma Product Sales Forecast
10.3. Europe Glioblastoma Market Share Analysis

11. Japan Glioblastoma Market Insights
11.1. Marketed Drugs for Glioblastoma in Japan
11.2. Japan Glioblastoma Market Size & Forecast
11.3. Japan Glioblastoma Product Sales Forecast
11.4. Japan Glioblastoma Market Share Analysis

12. Global Glioblastoma Market Insights
12.1. Global Glioblastoma Market Size & Forecast
12.2. Global Glioblastoma Product Sales Forecast
12.3. Global Glioblastoma Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Glioblastoma Phase 3 Clinical Trials, Global, 2020
Table 2: Glioblastoma Phase 2 Clinical Trials, Global, 2020
Table 3: Glioblastoma Phase 1 Clinical Trials, Global, 2020
Table 4: Glioblastoma Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Glioblastoma in US, 2019
Table 6: US Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Glioblastoma Product Sales ($mn), 2016 - 2024
Table 8: US Glioblastoma Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Glioblastoma in Germany, 2019
Table 10: Germany Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Glioblastoma Product Sales ($mn), 2016 - 2024
Table 12: Germany Glioblastoma Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Glioblastoma in France, 2019
Table 14: France Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Glioblastoma Product Sales ($mn), 2016 - 2024
Table 16: France Glioblastoma Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Glioblastoma in Italy, 2019
Table 18: Italy Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Glioblastoma Product Sales ($mn), 2016 - 2024
Table 20: Italy Glioblastoma Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Glioblastoma in Spain, 2019
Table 22: Spain Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Glioblastoma Product Sales ($mn), 2016 - 2024
Table 24: Spain Glioblastoma Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Glioblastoma in UK, 2019
Table 26: UK Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Glioblastoma Product Sales ($mn), 2016 - 2024
Table 28: UK Glioblastoma Market Events and Trends, 2016 - 2024
Table 29: Europe Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Glioblastoma Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Glioblastoma in Japan, 2019
Table 32: Japan Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Glioblastoma Product Sales ($mn), 2016 - 2024
Table 34: Japan Glioblastoma Market Events and Trends, 2016 - 2024
Table 35: Global Glioblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Glioblastoma Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Glioblastoma Pipeline by Phase (%), Global, 2020
Figure 2: Glioblastoma Prevalence by Countries, 2016 - 2024
Figure 3: US Glioblastoma Market Size ($mn), 2016 - 2024
Figure 4: US Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 5: US Glioblastoma Market Share by Drugs (%), 2019
Figure 6: US Glioblastoma Market - Future Market Share (%), 2024
Figure 7: Germany Glioblastoma Market Size ($mn), 2016 - 2024
Figure 8: Germany Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 9: Germany Glioblastoma Market Share by Drugs (%), 2019
Figure 10: Germany Glioblastoma Market - Future Market Share (%), 2024
Figure 11: France Glioblastoma Market Size ($mn), 2016 - 2024
Figure 12: France Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 13: France Glioblastoma Market Share by Drugs (%), 2019
Figure 14: France Glioblastoma Market - Future Market Share (%), 2024
Figure 15: Italy Glioblastoma Market Size ($mn), 2016 - 2024
Figure 16: Italy Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 17: Italy Glioblastoma Market Share by Drugs (%), 2019
Figure 18: Italy Glioblastoma Market - Future Market Share (%), 2024
Figure 19: Spain Glioblastoma Market Size ($mn), 2016 - 2024
Figure 20: Spain Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 21: Spain Glioblastoma Market Share by Drugs (%), 2019
Figure 22: Spain Glioblastoma Market - Future Market Share (%), 2024
Figure 23: UK Glioblastoma Market Size ($mn), 2016 - 2024
Figure 24: UK Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 25: UK Glioblastoma Market Share by Drugs (%), 2019
Figure 26: UK Glioblastoma Market - Future Market Share (%), 2024
Figure 27: Europe Glioblastoma Market Size ($mn), 2016 - 2024
Figure 28: Europe Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 29: Europe Glioblastoma Market Share by Drugs (%), 2019
Figure 30: Europe Glioblastoma Market - Future Market Share (%), 2024
Figure 31: Japan Glioblastoma Market Size ($mn), 2016 - 2024
Figure 32: Japan Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 33: Japan Glioblastoma Market Share by Drugs (%), 2019
Figure 34: Japan Glioblastoma Market - Future Market Share (%), 2024
Figure 35: Global Glioblastoma Market Size ($mn), 2016 - 2024
Figure 36: Global Glioblastoma Product Sales ($mn), 2016 - 2024
Figure 37: Global Glioblastoma Market Share by Drugs (%), 2019
Figure 38: Global Glioblastoma Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll